KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Medpace Holdings (MEDP) Shares Repurchased (2017 - 2025)

Medpace Holdings (MEDP) has disclosed Shares Repurchased for 7 consecutive years, with $4.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Repurchased changed N/A year-over-year to $4.6 million, compared with a TTM value of $917.4 million through Dec 2025, up 440.06%, and an annual FY2025 reading of $917.4 million, up 440.06% over the prior year.
  • Shares Repurchased was $4.6 million for Q3 2025 at Medpace Holdings, down from $540.9 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $540.9 million in Q2 2025 and bottomed at $4.6 million in Q3 2025.
  • Average Shares Repurchased over 5 years is $194.7 million, with a median of $120.1 million recorded in 2023.
  • The sharpest move saw Shares Repurchased soared 570.61% in 2022, then crashed 93.63% in 2023.
  • Year by year, Shares Repurchased stood at $6.2 million in 2021, then soared by 658.68% to $47.2 million in 2022, then tumbled by 49.4% to $23.9 million in 2023, then surged by 611.51% to $169.9 million in 2024, then tumbled by 97.31% to $4.6 million in 2025.
  • Business Quant data shows Shares Repurchased for MEDP at $4.6 million in Q3 2025, $540.9 million in Q2 2025, and $371.9 million in Q1 2025.